PRK and LASIK reduces retinal image quality

Article

Performing photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) reduces the retinal image quality in myopic patients.

Performing photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) reduces the retinal image quality in myopic patients, declared a paper in the Journal of Cataract and Refractive Surgery.

The comparative case series, headed by Dr Meritxell Vilaseca, Universitat Politècnica de Catalunya, Terrassa, Barcelona Institute of Ocular Microsurgery, Barcelona, Spain, assessed 34 myopic eyes that underwent PRK and 55 myopic eyes that underwent LASIK.

Preoperatively and 3 months after PRK or LASIK optical quality was assessed with a clinical double-pass system. The team calculated the modulation transfer function (MTF), retinal image quality parameters (MTF cut-off frequency, Strehl ratio), and intraocular scattering [objective scatter index (OSI)].

PRK and LASIK demonstrated a statistically significant reduction on retinal image quality. However, there were no differences in reduction between the two techniques.

In the PRK group the MTF decreased by a factor of 1.50 and in the LASIK group it decreased by 1.32. The Strehl ratio was decreased by 1.10 and 1.07 for the PRK and LASIK group, respectively.

PRK and LASIK caused an increase in the objective scatter index by factors of 1.48 and 1.57, respectively. The preoperative refraction and the OSI were strongly linked.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.